T Cell News and Research

Latest T Cell News and Research

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Researchers from Qatar have demonstrated that antibody repertoires against endemic human coronaviruses are qualitatively different in children when compared to the general adult population, as well as healthy adult blood bank donors – and they may also provide cross-protection against epidemic/pandemic strains.

23 Jun 2020

Pangolin version of SARS-CoV-2 can cause COVID-19-like illness

The results of a recent multinational research endeavor, currently available on the bioRxiv preprint server, display the biological framework of SARS-CoV-2-related coronavirus in pangolins and reveal striking similarities to coronavirus disease (COVID-19) in humans, but also show that it can be transmitted vertically to the fetus.

23 Jun 2020

Female reproductive organs not susceptible to direct SARS-CoV-2 infection

Researchers at the University in San Francisco, California, report that coronavirus disease 2019 (COVID-19) is unlikely to negatively impact on pregnancy-related outcomes such as premature birth, transmission to babies via breast milk, and infertility.

23 Jun 2020

Novel treatment provides cardioprotection after heart attack in animal models

A novel treatment reduces heart damage after serious heart attacks in two animal models. Injections of two chemicals in a slow-release form significantly reduced the size of the dead heart tissue, known as the infarct, and improved the function of the left ventricle, as compared to untreated subjects.

23 Jun 2020

Producing CAR T cell therapy at a lower cost

Chimeric antigen receptor (CAR) T cell therapy is a new and in some cases highly effective form of immunotherapy to treat certain types of cancer of the blood and lymph system.

23 Jun 2020

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting, and in select cases, undesired weight loss.

23 Jun 2020

St. Jude scientists create O-PDX models for pediatric brain tumor research

Scientists at St. Jude Children's Research Hospital have created orthotopic patient-derived xenograft (O-PDX) models representing a variety of pediatric brain tumor types.

23 Jun 2020

PCORI approves up to $50 million in funding for new projects to address COVID-19

The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors today, building on its rapid response to the COVID-19 health crisis, approved allocating up to $50 million in additional funding for new projects in PCORI's COVID-19 funding opportunities, as well as enhancements to existing PCORI-funded studies.

23 Jun 2020

FDA approved drugs active against COVID-19

With the rapid spread of the virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) throughout the world, causing the current COVID-19 pandemic, there is an urgent need for new antivirals and vaccines to combat its spread. The current study published on the preprint server bioRxiv in June 2020 shows some of the results of the extensive repurposing of already FDA-approved drugs.

23 Jun 2020

Woman's immune system behaves differently between first and later pregnancies

Among the holy quests of serious and mysterious medical challenges that doctors and research scientists strive to vanquish is preventing miscarriages, stillbirth and other pregnancy complications including preterm births.

23 Jun 2020

Research reveals new insights into molecular circuitry controlling cancer growth and spread

Research led by Queen Mary University of London has revealed novel insights into the molecular circuitry controlling cancer cell growth and spread.

23 Jun 2020

First clinical trial in South Africa for Covid-19 vaccine begins

The first clinical trial in South Africa and on the continent for a Covid-19 vaccine was announced today, 23 June 2020, at a virtual press conference hosted by the University of the Witwatersrand, Johannesburg (Wits).

23 Jun 2020

Blocking a pair of sugar-transporting proteins impairs lung tumor growth

Blocking a pair of sugar-transporting proteins may be a useful treatment approach for lung cancer, suggests a new study in mice and human cells published today in eLife.

23 Jun 2020

Long-term endurance training alters the activity of genes involved in metabolic health

Decades-long endurance training alters the activity of genes in human skeletal muscle that are important for metabolic health.

23 Jun 2020

Prevention of sugar uptake can make cancer cells more sensitive to chemotherapy

By preventing sugar uptake, researchers succeeded in increasing the cancer cells' sensitivity to chemotherapeutic treatment.

23 Jun 2020

Hungarian physician to receive the Körber Prize for European Science 2020

The Körber Prize for European Science 2020, which is endowed with one million euros, is being awarded to the Hungarian physician Botond Roska.

23 Jun 2020

Defective maintenance puts intestinal health in danger

In order to keep the intestinal mucosa and the entire organism healthy, intestinal epithelial cells have developed various protective functions involving a number of maintenance mechanisms that protect cells from stress.

23 Jun 2020

Improving cancer therapies by exploiting drug resistance in cancer

News-Medical talks to Professor David Thomas about his recent research identifying the mechanisms behind cancer cells developing resistance to drugs.

23 Jun 2020

ACCC releases preliminary results from survey on stage III and IV lung cancer care

The Association of Community Cancer Centers today released preliminary results and an initial set of quality care recommendations from Fostering Excellence in Care and Outcomes in Patients with Stage III and IV NSCLC, an initiative to improve care delivery and outcomes for advanced non-small cell lung cancer (NSCLC) patients.

23 Jun 2020

Research shows females use anti-inflammatory T cells to maintain their blood pressure

In the face of a multipronged front to drive blood pressure up, including a high-salt diet, females are better able to keep their pressure down by increasing levels of a T cell that selectively dials back inflammation, scientists say.

23 Jun 2020

T Cell News and Research

Latest T Cell News and Research

Antibodies against prevalent endemic human coronaviruses may provide cross-protection to SARS-CoV-2

Pangolin version of SARS-CoV-2 can cause COVID-19-like illness

Female reproductive organs not susceptible to direct SARS-CoV-2 infection

Novel treatment provides cardioprotection after heart attack in animal models

Producing CAR T cell therapy at a lower cost

Chemist develops new drug to treat type 2 diabetes without undesired side effects

St. Jude scientists create O-PDX models for pediatric brain tumor research

PCORI approves up to $50 million in funding for new projects to address COVID-19

FDA approved drugs active against COVID-19

Woman's immune system behaves differently between first and later pregnancies

Research reveals new insights into molecular circuitry controlling cancer growth and spread

First clinical trial in South Africa for Covid-19 vaccine begins

Blocking a pair of sugar-transporting proteins impairs lung tumor growth

Long-term endurance training alters the activity of genes involved in metabolic health

Prevention of sugar uptake can make cancer cells more sensitive to chemotherapy

Hungarian physician to receive the Körber Prize for European Science 2020

Defective maintenance puts intestinal health in danger

Improving cancer therapies by exploiting drug resistance in cancer

ACCC releases preliminary results from survey on stage III and IV lung cancer care

Research shows females use anti-inflammatory T cells to maintain their blood pressure

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in